Status:
UNKNOWN
Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid
Lead Sponsor:
PT. Prodia Stem Cell Indonesia
Conditions:
Keloid
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
PHASE2
Brief Summary
The clinical trial will be carried out at the Gatot Soebroto Army Central Hospital, Jakarta and planned from June 2020 to December 2020. Clinical trials of Umbilical Cord-Mesenchymal Stem Cells (UC-MS...
Eligibility Criteria
Inclusion
- Surgery history of more than 3 months
- Has keloid that the maximum size is 15 cm and thickness is 3-5 mm
Exclusion
- Patients with kidney failure
- Pregnancy
- Breastfeeding
- Liver dysfunction
- Blood disorders
- Currently receiving immunosuppressant therapy (chemotherapy or steroids)
- Refusing to participate in the study
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04326959
Start Date
September 1 2020
End Date
December 1 2020
Last Update
July 15 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.